IPCA Laboratories: The financial results for the period ended September 30, 2026
IPCA Laboratories (IPCALAB) filed a disclosure titled "The financial results for the period ended September 30, 2026". The company is valued at about ₹49,241 crore.
What happened
IPCA Laboratories (IPCALAB) filed a disclosure with the exchanges on 5 November 2026 at 01:42 PM titled "The financial results for the period ended September 30, 2026".
Company snapshot
IPCA Laboratories is a mid-cap company in the Healthcare sector, with a market value of about ₹49,241 crore.
The stock last traded at ₹1,940.9, against a 52-week range of ₹1,276.1–₹2,038 (4.8% below the high).
Before this filing the shares had moved +0.4% over the month and +15.1% over three months. Average daily turnover over the last 20 sessions was about ₹47.79 crore.
Promoters held 44.72% at the end of Q1 FY27. Foreign institutions owned 10.73% and domestic institutions 37.37%.
| Quarter | Revenue | Net profit | EPS (₹) |
|---|---|---|---|
| Q1 FY26 | 2,309 | 233.2 | 9.19 |
| Q2 FY26 | 2,557 | 282.6 | 11.14 |
| Q3 FY26 | 2,393 | 326.3 | 12.86 |
| Q4 FY26 | 2,388 | 299.1 | 11.79 |
| Q1 FY27 | 2,788 | 401.9 | 15.84 |
What history shows
BCEIE's records show 3 previous results filings from the company since May 2026.
After those filings, the stock fell 1.8% on average the next trading day and was up 7.6% on average after five days (2 filings with price data).
Across 300 similar disclosures by other Healthcare companies, shares moved +1.4% on average the next day and +1.9% over five days; 58% of them rose the next day.
Market-wide, 10,790 results filings with an impact score of 50 or more saw an average next-day move of −0.3%, with 42% rising.
Past reactions describe what happened before; they are not a forecast.
| Date | Filing | Next day | 5 days |
|---|---|---|---|
| 13 Aug 2026 | Standalone And Consolidated Unaudited Financial Results For Q1FY27 | −1.8% | +7.6% |
| 13 Aug 2026 | Board Meeting Outcome for Standalone And Consolidated Unaudited… | −1.8% | +7.6% |
What to watch
- Management commentary, margins and order book or guidance in the investor presentation.
- 5 November 2026: Board meeting — Financial Results.
In the news
Recent coverage elsewhere (links open the original publisher):
Source
Automatically written from the exchange filing and BCEIE data. Not investment advice. Check the original filing before acting on it.